Literature DB >> 8082507

Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man.

J W Marks1, T Stein, L J Schoenfield.   

Abstract

Cholesterol gallstones form frequently among obese patients during rapid loss of weight. The aims of the present study were to determine the short-term natural history of these gallstones and the efficacy of ursodiol for their dissolution. Twenty-two patients whose gallstones had formed during rapid loss of weight were randomized in double-masked fashion to either ursodiol, 1200 mg/day, or placebo for nine months. Ultrasonography of the gallbladder was performed after three and nine months of treatment. All patients without disappearance of their gallstones after nine months received open-label ursodiol for an additional nine months with ultrasonography after three and nine months. Among the patients completing three months of masked treatment, disappearance of gallstones was seen in five of 11 patients who received placebo and four of seven patients who received ursodiol. Only one additional patient of six continuing placebo for nine months experienced disappearance. Neither of two patients continuing ursodiol for nine months had disappearance of gallstones. None of the five patients treated with open-label ursodiol for nine months had disappearance of gallstones. Thus, half of the gallstones that form during rapid loss of weight disappear rapidly once loss of weight ceases; ursodiol may not increase the frequency or rapidity of their disappearance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082507     DOI: 10.1007/bf02088135

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Risk factors for gallstone formation during rapid loss of weight.

Authors:  H Yang; G M Petersen; M P Roth; L J Schoenfield; J W Marks
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

2.  Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.

Authors:  P H Broomfield; R Chopra; R C Sheinbaum; G G Bonorris; A Silverman; L J Schoenfield; J W Marks
Journal:  N Engl J Med       Date:  1988-12-15       Impact factor: 91.245

3.  Chemical composition of gallstones resistant to dissolution therapy with chenodeoxycholic acid.

Authors:  M J Whiting; V Jarvinen; J M Watts
Journal:  Gut       Date:  1980-12       Impact factor: 23.059

4.  Prevalence and treatment of gall stones after gastric bypass surgery for morbid obesity.

Authors:  D A Wattchow; J C Hall; M J Whiting; B Bradley; J Iannos; J M Watts
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-05

5.  Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy.

Authors:  J R Walters; K A Hood; D Gleeson; J P Ellul; A Keightley; G M Murphy; R H Dowling
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

6.  Effects of obesity and caloric intake on biliary lipid metabolism in man.

Authors:  L J Bennion; S M Grundy
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

7.  Gallstone formation during weight-reduction dieting.

Authors:  R A Liddle; R B Goldstein; J Saxton
Journal:  Arch Intern Med       Date:  1989-08

8.  Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity.

Authors:  M L Shiffman; H J Sugerman; J M Kellum; W H Brewer; E W Moore
Journal:  Am J Gastroenterol       Date:  1991-08       Impact factor: 10.864

9.  Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.

Authors:  M Podda; M Zuin; P M Battezzati; C Ghezzi; C de Fazio; M L Dioguardi
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

Review 10.  Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety.

Authors:  L J Schoenfield; J M Lachin
Journal:  Ann Intern Med       Date:  1981-09       Impact factor: 25.391

View more
  3 in total

Review 1.  Evidence-based clinical practice guidelines for cholelithiasis 2016.

Authors:  Susumu Tazuma; Michiaki Unno; Yoshinori Igarashi; Kazuo Inui; Kazuhisa Uchiyama; Masahiro Kai; Toshio Tsuyuguchi; Hiroyuki Maguchi; Toshiyuki Mori; Koji Yamaguchi; Shomei Ryozawa; Yuji Nimura; Naotaka Fujita; Keiichi Kubota; Junichi Shoda; Masami Tabata; Tetsuya Mine; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-12-10       Impact factor: 7.527

2.  Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).

Authors:  Thomas C C Boerlage; Sylke Haal; L Maurits de Brauw; Yair I Z Acherman; Sjoerd Bruin; Arnold W J M van de Laar; Daan E Moes; Bart A van Wagensveld; Claire E E de Vries; Ruben van Veen; Ruben Schouten; Marcel G Dijkgraaf; Paul Fockens; Victor E A Gerdes; Rogier P Voermans
Journal:  BMC Gastroenterol       Date:  2017-12-20       Impact factor: 3.067

Review 3.  Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family Physicians.

Authors:  Piero Portincasa; Agostino Di Ciaula; Ignazio Grattagliano
Journal:  Korean J Fam Med       Date:  2016-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.